Persistent Vaccination Effect of GRAZAX(R) After Completion of Treatment

Wednesday 22nd of October 2008 6:02

• Persistent Vaccination Effect of GRAZAX(R) After Completion of ... Persistent Vaccination Effect of GRAZAX(R) After Completion of Treatment. Wed Oct 22, 2008 6:05am EDT. Email | Print |. Share. | Reprints | Single Page ...
  http://www.reuters.com/article/pressRelease/idUS104446+22-Oc...
  
  
• PR Newswire Press Releases on Statesman.com 22 Oct 2008 ... COPENHAGEN, October 22 /PRNewswire-FirstCall/ -- Breakthrough: Results from the fourth year in a long-term clinical study prove the disease ...
  http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=AUSASBIO.s...
  
  
• PR Newswire - A United Business Media Company 10:02, Persistent Vaccination Effect of GRAZAX(R) After Completion of Treatment. Monday 17 March 2008. 10:45, ALK-Abelló, le fabricant du GRAZAX(R) présente ...
  http://www.prnewswire.co.uk/cgi/news/company?id=208528...
  
  
• NurseWeek: PR Newswire 22 Oct 2008 ... Persistent Vaccination Effect of GRAZAX(R) After Completion of Treatment COPENHAGEN, October 22 /PRNewswire-FirstCall/ -- Breakthrough: ...
  http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=NRSWK.stor...
  
  
• Archive News & Video for Wednesday, 22 Oct, 2008 | Reuters.com REG-ABN AMRO BANK N.V. EPT Disclosure 06:06 AM EDT. Persistent Vaccination Effect of GRAZAX(R) After Completion of Treatment 06:05 AM EDT ...
  http://www.reuters.com/resources/archive/us/20081022.html...
  
  

Related Web-Links

• Microsoft PowerPoint - FY2008_final
• Allergen immunotherapy - Wikipedia, the free encyclopedia
• Microsoft PowerPoint - General IR_Q3_2008-updated by PPI
• Immunotherapy - Wikipedia, the free encyclopedia
• Microsoft PowerPoint - General IR_H1-09

Source PR Newswire


www.prnewswire.co.uk

Browse news from 2008

Download PDF